Novel Compound, Production Method Therefor, And Pharmaceutical Composition - EP4293013
The patent EP4293013 was granted to National Cancer Center on Aug 20, 2025. The application was originally filed on Jan 28, 2022 under application number EP22752615A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4293013
- Application Number
- EP22752615A
- Filing Date
- Jan 28, 2022
- Status
- Granted And Under Opposition
- Jul 18, 2025
- Publication Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents